🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joseph J. Drabick

Penn State Milton S. Hershey Medical Center

ORCID: 0000-0002-7630-2721
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.2Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.27784
Top 15%
1.3DataRank
Top 15%32 citations

Chachrit Khunsriraksakul, Samantha Acri, Dajiang J. Liu, Djibril M. Ba, John Lin +6 more

Papers

Driven by 7 papers — median percentile 81. Top paper: “Passive Protection of Mice Against Lethal Francisella Tularensis (Live Tularemia Vaccine Strain) Infection by the Sera of Human Recipients of the Live Tularemia Vaccine”.

Passive Protection of Mice Against Lethal Francisella Tularensis (Live Tularemia Vaccine Strain) Infection by the Sera of Human Recipients of the Live Tularemia Vaccine

The American Journal of the Medical Sciences(1994)10.1097/00000441-199408000-00003
N/A
3.9DataRank · unranked
70 citations

R.B. Narayanan, Jim C. Williams, James W. Leduc, Carol A. Nacy, Joseph J. Drabick

Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.27784
Top 15%
1.3DataRank
Top 15%32 citations

Chachrit Khunsriraksakul, Samantha Acri, Dajiang J. Liu, Djibril M. Ba, John Lin +6 more

Prognostic Value of DNA Damage Response Genomic Alterations in Relapsed/Advanced Urothelial Cancer

The Oncologist(2020)10.1634/theoncologist.2019-0851
Top 22%
0.905DataRank
Top 22%21 citations

Petros Grivas, Qi-En Wang, Amir Mortazavi, Hamid Emamekhoo, Sheldon L. Holder +9 more

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2381
N/A
0DataRank · unranked
145 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Toxicity in combination immune checkpoint inhibitor and radiation therapy: A systematic review and meta-analysis

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.07.035
N/A
0DataRank · unranked
99 citations

Eric J. Lehrer, Clara Hwang, Daniel M. Trifiletti, Heath B. Mackley, Joseph J. Drabick +2 more

Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

(2023)10.1158/1078-0432.c.6530279
N/A
0DataRank · unranked
0 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331
N/A
0DataRank · unranked
125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more